Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Aker Solutions ASA: Transactions made under the buy-back programme

July 15, 2024 – On February 12, 2024, Aker Solutions ASA (“Aker Solutions”) announced a share buy-back program of up to NOK 500 million, with a maximum of 12.5 million shares, in the period from 12 February 2024 to 31 July 2024.Upon the successful completion of the transactions below, Aker Solutions has fulfilled the objectives of the share buy-back program. DNB, acting under an irrevocable mandate from Aker Solutions, has carried out the following transactions under the buy-back program:   +--------------------+----------+-------------+-----------------------+| Date

SEB completes latest share buyback programme and initiates new programme

SEB has completed its latest share buyback programme, under which SEK 2 billion of Class A shares have been repurchased. The Board of Directors has resolved to utilise the authorisation granted by the 19 March 2024 Annual General Meeting to initiate a new SEK 2.5 billion buyback programme of Class A shares.  On 19 March 2024, SEB announced a SEK 2 billion share buyback programme for capital management purposes. The repurchases of shares began on 20 March 2024 and ended on 12 July 2024. During this period, SEB repurchased 13,329,653 of its own Class A shares at an average price per share

Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization

Oslo, Norway, July 15, 2024: Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announces that it has entered into a strategic agreement with Richard Wolf GmbH to develop and commercialize a next-generation 4K LED high-definition (HD) reusable flexible blue light cystoscope based on Richard Wolf’s System blue technology. The partnership between Photocure and Richard Wolf is focused on developing technologically advanced flexible blue light cystoscopy (BLC[®]) equipment for the global market so that physicians who treat patients with bladder cancer can offer the benefits of BLC with

Relais Group Plc: Share Repurchase 15.7.2024

Relais Group Plc  ANNOUNCEMENT  15.7.2024 Relais Group Plc: Share Repurchase 15.7.2024 In the Helsinki Stock Exchange Trade date           15.7.2024Bourse trade         BuyShare                  RELAISAmount             650 SharesAverage price/ share    13,5000 EURTotal cost            8 775,00 EUR Relais Group Plc now holds a total of 33 657 sharesincluding the shares repurchased on 15.7.2024 On behalf of Relais Group Plc Nordea Bank Oyj Janne

Exel Composites Plc: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act

EXEL COMPOSITES PLC          STOCK EXCHANGE RELEASE        15 JULY 2024 AT 18:00 EESTExel Composites Plc has on 15 July 2024 received a notification pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act, according to which the holding of funds managed by OP Fund Management Company Ltd has decreased below 5% of the voting rights and share capital in Exel Composites Plc. Through share transactions concluded on 12 July 2024, the holding of funds managed by OP Fund Management Company Ltd amounts to 5,334,412 shares representing 4.998% of the shares and voting rights of Exel

#24-251 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#24-250 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Storskogen receives consent from bondholders in written procedures

Storskogen Group AB (publ) (“Storskogen”) announces that the written procedures (the “Written Procedures”) which were initiated on 26 June 2024 under the terms and conditions for Storskogen’s outstanding bonds 2021/2025 (ISIN: SE0017084650), bonds 2023/2027 (ISIN: SE0020358026) and bonds 2024/2027 (ISIN: SE0022240974) (the “Terms and Conditions” and the “Bonds” respectively) have been successfully concluded. The Written Procedures were initiated in connection with the decision to divest nine business units, as announced in the press release on 25 June 2024. This divestment was undertaken

Buy-back of shares in Hemnet during 8 - 12 July, 2024

Hemnet Group AB (publ) (LEI code: 5493008VIU67J3HUAR07) ("Hemnet") has during 8 to 12 July 2024 repurchased in total 16,000 own ordinary shares (ISIN code: SE0015671995) as part of the share buy-back program initiated by the board of directors of Hemnet in order to adjust Hemnet's capital structure.The share buy-backs form part of the share buy-back program of maximum SEK 450,000,000 announced by Hemnet on 25 April 2024. The share buy-back program is being carried out in accordance with the EU Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU)

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0003322319 Issuer Name FIDELITY ASIAN VALUES PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Rathbones Investment Management Ltd City of registered office (if applicable) London Country of registered office (if applicable) United Kingdom +------------------------+----------+----------------------------+|Name |City of |Country

Fiven ASA publishes sustainability-linked bond progress report

As announced on 21 June 2024, Fiven ASA ("Fiven") intends to redeem its outstanding EUR 110,000,000 senior secured sustainability-linked floating rate bonds with ISIN SE0021148764 (the "Bonds"). In accordance with the terms and conditions for the Bonds (the "Terms and Conditions"), a Sustainability-Linked Bond Progress Report (as defined in the Terms and Conditions) has been published as of today and is available on Fiven's website. Fiven will publish a separate call notice before the redemption of the Bonds in accordance with Terms and Conditions.     For further information,

KlaraBo acquires residential properties and divests commercial properties to Diös Fastigheter

KlaraBo has today signed an agreement to acquire the properties Hälsinggården 12:1 and 1:341 in Falun. These properties are purely residential, fitting well into KlaraBo’s business model of value-creating management. The acquisition includes 80 apartments, with an area of 5,800 sqm, and an underlying value of 80 million SEK, with 80 percent of the apartments estimated to have renovation potential. The rental value amounts to SEK 7 million, and the acquisition is made through a newly established company. Simultaneously, KlaraBo is divesting the properties Skräddaren 2 and Sigge 5 in

CS MEDICA Announces Strategic Partnerships to Enhance Funding

Securing New Capital and Strengthening Shareholder Relations Through Strategic CollaborationsCS MEDICA, a pioneering MedTech company specializing in pain management and autoimmune diseases with innovative substance-based medical devices containing bioactive CBD, announces a direct issue of 1.5 MDKK with Börsjakten AB at a share price of 3.00 DKK. This initiative is part of our broader strategy to secure short-term capital while preparing for a larger funding round, pending approval at the upcoming EGM. Additionally, we are excited to unveil three strategic collaborations aimed at enhancing

CS MEDICA A/S: Notice of Extraordinary General Meeting

The shareholders of CS MEDICA A/S ("CS MEDICA" or the "Company") are hereby notified of an Extraordinary General Meeting to be held on Wednesday 31, 2024, at 09:00 at TEAMS.Proposed agenda 1. Election of chairman of the meeting 2. Proposal to make a capital increase of 317.000 shares for DKK 3,00 per share without pre-emption right for the existing shareholders. The capital increase can be subscribed by Börsjakten AB or companies/persons related to Börsjakten AB, including its investor network. The shares are offsetting a remuneration for an IR agreement amounting to SEK 1.450.000.

Publication of Registration Document

Regulatory Announcement RNS Number: 4592W Royal Bank of Canada July 15, 2024 Publication of Registration Document Not for release, publication or distribution, directly or indirectly, in or into the United States. The following registration document has been approved by the Financial Conduct Authority and, along with the documents incorporated by reference therein, is available for viewing: Registration Document dated July 15, 2024 relating to Royal Bank of Canada. The Registration Document, together with the documents incorporated by reference therein, have been

Invitation to Medicover’s results presentation for Q2 2024

Medicover’s (MCOV B) Q2 report 2024 will be published on 25 July at 07.45 CEST. The Company will hold a conference call (in English) for media, financial analysts and investors at 09.30 CEST. The report will be presented by CEO Fredrik Rågmark and CFO Joe Ryan and followed by a question-and-answer session. Shortly before the webcast, presentation slides will be available on medicover.com . To access live webcast register here . To dial in and ask questions register here (

Buy-back of shares in Arise during week 28, 2024

During the period between 8 July and 12 July 2024 Arise AB (publ) (LEI code 549300FOT7EE85QYB655) (“Arise”) repurchased, in total, 44,896 own shares (ISIN code SE0002095604) under the share repurchase program initiated by the Board of Directors to deliver shareholder value and to optimize the capital structure of the company. The share buy-backs form a part of the share repurchase program of a maximum amount of SEK 50 million, which Arise announced on 7 May 2024. The share repurchase program, which runs from 8 May 2024 until the date of Arise's Annual General Meeting in 2025, is being

F-1 Filed in the USA

15 July 2024   Rogue Baron plc (‘Rogue Baron’ or the ‘Company’)   F-1 Filed in the USA   Rogue Baron plc (AQSE: SHNJ), a leading company in the premium spirit sector, is pleased to announce that following on from its announcement of 10 April 2024 regarding the appointment of a US broker, the Company has now filed its Form F-1 with the US Securities and Exchange Commission.   F-1 is the registration statement form most commonly used by foreign private issuers (certain non-US companies) selling securities in a registered offering in the US for the first time.

Assemblin Caverion Group publishes Q2 2024 Interim Financial Information and invites investors to a webcast on 28 August 2024

Press release, 15 July 202414:00 CETAssemblin Caverion Group will publish its Q2 2024 Interim Financial Information (January–June) on 28 August, approximately at 08:30 CET. The Report is followed up by an investor webcast on the same day at 9:30 CET. Publishing the Report and briefing material The Report as well as briefing material will be released on the company’s website at https://www.assemblincaverion.com/investors/financial-reports. After the webcast, a recording will also be available there. To access the investor webcast The investor webcast (in English) will be held

There are no items matching the current filter
There are no more items matching the current filter
Back to top